CXCL1 and nasopharyngeal carcinoma: When antibodies specific for CXCL1, TPT1 or CD81 were added to tumor co-cultures with NPC, the suppressive effect by the NPC was significantly enhanced in several combinations of NPC and tumor, although to a varying extent.